“Efficacy of Oral DFD-29, a Low-Dose Minocycline Formulation, in Patients With Rosacea: A Pooled Analysis of Two Phase 3 Trials”, J of Skin, vol. 9, no. 6, p. s696, Nov. 2025, doi: 10.25251/p39dms53.